Moderate renal impairment does not preclude the accuracy of 24 hour urine normetanephrine measurements for suspected pheochromoctyoma
Clinical Endocrinology Mar 12, 2020
Kline GA, et al. - In this investigation, researchers tested the assumption that there would be an inverse link between eGFR and 24 hour urine nor/metanephrine(urine NM-MN) measurements in which case such testing would be considered confounded when renal impairment was present. In addition, they determined the degree to which plasma NM-MN results were affected in connection with mild-to-moderate renal impairment. The entire urine NM-MN database involved 15,505 samples from 13,525 unique patients with a median age of 51.2 years (37.5-63) and 58.3% female, 41.5% male. There was no continuous gradient between subnormal renal function and urine NM-MN measures in patients with mild-to-moderate renal impairment. The hypothesized effect on lowered urine NM-MN was evident when the estimated GFR was < 15 ml/min/m2. Measurement of 24-hour NM-MN urine is unlikely to be affected by mild-to-moderate renal impairment and may be used as a valid diagnostic test. CKD-specific reference ranges or an alternative test may be required with more advanced renal impairment.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries